Senior insider sale
Chief Commercial Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$127.6K
14.32K shares
What this filing means
MEYERS STEVE LAWRENCE plans to sell 14.32K shares of OCULAR THERAPEUTIX, INC valued at approximately $127.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/12/2026ACC: 0001950047-26-001204
Officer· Chief Commercial Officer
Since Jun 2025
14.32K
Shares to sell
$127.6K
Approx. market value
6.86K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
2/11/2026
6.86KTotal acquired6.86K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/11/2026 | Restricted stock vesting under a registered plan Not Applicable | 6.86K | — |
| Total | 6.86K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
4.41K
Market value
$37.6K
2/4/2026
—Completed
Units to sell
3.05K
Market value
$27.9K
2/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.86K
Market value
$62.0K
2/12/2026
Total
Units
14.32K
Value
$127.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/4/2026 | 4.41K | $37.6K | — | Completed |
2/2/2026 | 3.05K | $27.9K | — | Completed |
| Planned — Approximate Date | ||||
2/12/2026 | 6.86K | $62.0K | NASDAQ | Planned |
| Total | 14.32K | $127.6K | ||